General Information
Revision date
2022-11-15
Product name
7.7% TEAl in Heptane
Substance name
substance or or or or mixture
REACH No
1.2
1.2.1 Relevant identified uses
uses advised
1.2.2. Uses advised against
advised against
Emergency telephone
+91 2662 229200
Icons in SDS
Company Information
company name
Gulbrandsen Private Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gpl-msds@gulbrandsen.com, duconfirmation@reachlaw.fi
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H250, H260, H304, H314, H336, H410
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)] 2.1
Classifications
Classification of of of of the the the substance substance substance or or or or mixture mixture
2.2 Label elements
elements
Hazard pictograms
GHS02 GHS05 GHS08 GHS07 GHS09
Signal word
Danger.
Hazard statements
H225: Highly flammable liquid and vapour. H250: Catches fire spontaneously if exposed to air. H260: In contact with water releases flammable gases which may ignite spontaneously. H304: May be fatal if swallowed and enters airways. H314: Causes severe skin burns and eye damage. H336: May cause drowsiness or dizziness. H410: Very toxic to aquatic life with long lasting effects. EUH014: Reacts violently with water.
Precautionary statements
P210: Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P260: Do not breathe vapour. P273: Avoid release to the environment. P280: Wear protective gloves/protective clothing/eye protection/face protection. P303+P361+P353 IF ON SKIN (or hair) Take off immediately all contaminated clothing. Rinse skin with water. P305+P351+P338 IF IN EYES Rinse cautiously with water for several minutes Remove contact lenses, if present and easy to do. Continue rinsing. 2.3 2.3 Other Other
2.3 Other hazards
None known. 2.4 2.4 Additional
Additional information
Additional Information For full text of H/P Statements see section 16.